{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:48:07Z","timestamp":1782708487214,"version":"3.54.5"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006162","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Ci\u00eancia e Tecnologia do Estado de Pernambuco","doi-asserted-by":"publisher","award":["APQ-0040-4.00\/13"],"award-info":[{"award-number":["APQ-0040-4.00\/13"]}],"id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006507","name":"Funda\u00e7\u00e3o Oswaldo Cruz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["PROCAD-177382\/2013"],"award-info":[{"award-number":["PROCAD-177382\/2013"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["310364\/2015-9"],"award-info":[{"award-number":["310364\/2015-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.cyto.2017.07.014","type":"journal-article","created":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T10:30:17Z","timestamp":1502361017000},"page":"94-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Cytokines and soluble HLA-G levels in bone marrow stroma and their association with the survival rate of patients exhibiting childhood T-cell acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"102","author":[{"given":"Renata dos Santos","family":"Almeida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra Maria de Luna","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Feitosa","family":"Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1125-4308","authenticated-orcid":false,"given":"Francisco","family":"Pedrosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Ant\u00f4nio","family":"Donadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma","family":"Lucena-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2017.07.014_b0005","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","article-title":"Acute lymphoblastic leukaemia","volume":"371","author":"Pui","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2017.07.014_b0010","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2141.2011.08957.x","article-title":"T-cell acute lymphoblastic leukaemia: recent molecular biology findings","volume":"156","author":"Kraszewska","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cyto.2017.07.014_b0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pcl.2014.09.004","article-title":"Biology of Childhood Acute Lymphoblastic Leukemia","volume":"62","author":"Bhojwani","year":"2015","journal-title":"Pediatr. Clin. North Am."},{"key":"10.1016\/j.cyto.2017.07.014_b0020","first-page":"735","article-title":"Biology and treatment of childhood T-lineage acute lymphoblastic leukemia","volume":"91","author":"Uckun","year":"1998","journal-title":"Blood."},{"key":"10.1016\/j.cyto.2017.07.014_b0025","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2017.07.014_b0030","doi-asserted-by":"crossref","first-page":"6738","DOI":"10.1038\/sj.onc.1210758","article-title":"Aberrant cytokine signaling in leukemia","volume":"26","author":"Van Etten","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.cyto.2017.07.014_b0035","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/leu.2009.175","article-title":"Contribution of bone microenvironment to leukemogenesis and leukemia progression","volume":"23","author":"Ayala","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.cyto.2017.07.014_b0040","first-page":"414","article-title":"The role of microenvironment and immunity in drug response in leukemia","volume":"2016","author":"Bakker","year":"1863","journal-title":"Biochim. Biophys. Acta - Mol. Cell Res."},{"key":"10.1016\/j.cyto.2017.07.014_b0045","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/pbc.25359","article-title":"Going back to class I: MHC and immunotherapies for childhood cancer","volume":"62","author":"Haworth","year":"2015","journal-title":"Pediatr. Blood Cancer."},{"key":"10.1016\/j.cyto.2017.07.014_b0050","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.1158\/1078-0432.CCR-14-0879","article-title":"MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in Vitro","volume":"20","author":"Angell","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cyto.2017.07.014_b0055","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/carcin\/bgr318","article-title":"MHC class I molecules act as tumor suppressor genes regulating the cell cycle gene expression, invasion and intrinsic tumorigenicity of melanoma cells","volume":"33","author":"Garrido","year":"2012","journal-title":"Carcinogenesis."},{"key":"10.1016\/j.cyto.2017.07.014_b0060","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/ijc.24852","article-title":"The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer","volume":"126","author":"Bijen","year":"2010","journal-title":"Int. J. Cancer."},{"key":"10.1016\/j.cyto.2017.07.014_b0065","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1158\/1078-0432.CCR-14-1860","article-title":"Immune escape mechanisms as a guide for cancer immunotherapy","volume":"21","author":"Beatty","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cyto.2017.07.014_b0070","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/j.semcancer.2015.03.004","article-title":"Immune evasion in cancer: Mechanistic basis and therapeutic strategies","volume":"35","author":"Vinay","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.cyto.2017.07.014_b0075","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1593\/neo.05703","article-title":"Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages","volume":"8","author":"Gros","year":"2006","journal-title":"Neoplasia."},{"key":"10.1016\/j.cyto.2017.07.014_b0080","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-0039.2009.01302.x","article-title":"Characterization of HLA-G expression in renal cell carcinoma","volume":"74","author":"Li","year":"2009","journal-title":"Tissue Antigens."},{"key":"10.1016\/j.cyto.2017.07.014_b0085","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.humimm.2010.06.009","article-title":"Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer","volume":"71","author":"Chen","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.cyto.2017.07.014_b0090","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1399-0039.2011.01716.x","article-title":"Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer","volume":"78","author":"Cao","year":"2011","journal-title":"Tissue Antigens."},{"key":"10.1016\/j.cyto.2017.07.014_b0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000353757","article-title":"HLA-G expression as a prognostic indicator in B-cell chronic lymphocytic leukemia","volume":"132","author":"Attia","year":"2014","journal-title":"Acta Haematol."},{"key":"10.1016\/j.cyto.2017.07.014_b0100","doi-asserted-by":"crossref","first-page":"11520","DOI":"10.1073\/pnas.94.21.11520","article-title":"Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis","volume":"94","author":"Rouas-Freiss","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cyto.2017.07.014_b0105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000092537","article-title":"Cancer and pregnancy share similar mechanisms of immunological escape","volume":"52","author":"Wilczy\u0144ski","year":"2006","journal-title":"Chemotherapy."},{"key":"10.1016\/j.cyto.2017.07.014_b0110","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.imlet.2011.02.011","article-title":"The tolerogenic molecule HLA-G","volume":"138","author":"Carosella","year":"2011","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cyto.2017.07.014_b0115","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/297073","article-title":"HLA-G as a tolerogenic molecule in transplantation and pregnancy","volume":"2014","author":"Rebmann","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.cyto.2017.07.014_b0120","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00018-010-0580-7","article-title":"Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association","volume":"68","author":"Donadi","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cyto.2017.07.014_b0125","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/359748","article-title":"The dual role of HLA-G in cancer","volume":"2014","author":"Rouas-Freiss","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.cyto.2017.07.014_b0130","doi-asserted-by":"crossref","first-page":"782","DOI":"10.2119\/molmed.2015.00083","article-title":"HLA-G expression in cancers: roles in immune evasion, metastasis and target for therapy","author":"Lin","year":"2015","journal-title":"Mol. Med."},{"key":"10.1016\/j.cyto.2017.07.014_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071742","article-title":"Polymorphic sites at the 3\u2019 untranslated region of the HLA-G gene are associated with differential hla-g soluble levels in the Brazilian and French population","volume":"8","author":"Martelli-Palomino","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2017.07.014_b0140","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/intimm\/dxv002","article-title":"Association between sHLA-G and HLA-G 14-bp deletion\/insertion polymorphism in Crohn\u2019s disease","volume":"27","author":"Zidi","year":"2015","journal-title":"Int. Immunol."},{"key":"10.1016\/j.cyto.2017.07.014_b0145","first-page":"1","article-title":"The dimeric form of HLA-G molecule is associated with the response of early rheumatoid arthritis (ERA) patients to methotrexate","author":"Rizzo","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.cyto.2017.07.014_b0150","doi-asserted-by":"crossref","unstructured":"N.L. de Figueiredo-Feitosa, G. Martelli Palomino, D.C. Cili\u00e3o Alves, C.T. Mendes Junior, E.A. Donadi, L.M.Z. Maciel, HLA-G 3\u2032 untranslated region polymorphic sites associated with increased HLA-G production are more frequent in patients exhibiting differentiated thyroid tumours, Clin. Endocrinol. (Oxf)., 2017. 10.1111\/cen.13289.","DOI":"10.1111\/cen.13289"},{"key":"10.1016\/j.cyto.2017.07.014_b0155","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-103-4-620","article-title":"Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group","volume":"103","author":"Bennett","year":"1985","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cyto.2017.07.014_b0160","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12967-016-0894-9","article-title":"Increased Th17 cells and IL-17A exist in patients with B cell acute lymphoblastic leukemia and promote proliferation and resistance to daunorubicin through activation of Akt signaling","volume":"14","author":"Bi","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cyto.2017.07.014_b0165","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/cncr.23785","article-title":"The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes","volume":"113","author":"Tsimberidou","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.cyto.2017.07.014_b0170","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2174\/187153011794982059","article-title":"HLA-G expression in cancers: potential role in diagnosis, prognosis and therapy","volume":"11","author":"Yan","year":"2011","journal-title":"Endocr. Metab. Immune Disord. Drug Targets."},{"key":"10.1016\/j.cyto.2017.07.014_b0175","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.cyto.2012.12.023","article-title":"Cytokine profiles in acute myeloid leukemia patients at diagnosis: survival is inversely correlated with IL-6 and directly correlated with IL-10 levels","volume":"61","author":"Sanchez-Correa","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2017.07.014_b0180","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1182\/blood-2010-01-262071","article-title":"Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia","volume":"116","author":"Kornblau","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2017.07.014_b0185","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/blood.V97.1.256","article-title":"Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome","volume":"97","author":"Fayad","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2017.07.014_b0190","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1016\/S1470-2045(12)70582-X","article-title":"Cytokine patterns in patients with cancer: a systematic review","volume":"14","author":"Lippitz","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cyto.2017.07.014_b0195","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cytogfr.2014.07.016","article-title":"TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and future","volume":"25","author":"Sedger","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cyto.2017.07.014_b0200","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s002770050564","article-title":"Poor clinical outcome of patients with Hodgkin\u2019s disease and elevated interleukin-10 serum levels. Clinical significance of interleukin-10 serum levels for Hodgkin\u2019s disease","volume":"79","author":"Bohlen","year":"2000","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.cyto.2017.07.014_b0205","article-title":"Serum IL-10 predicts worse outcome in cancer patients: a meta-analysis","volume":"10","author":"Zhao","year":"2015","journal-title":"PLoS One."},{"key":"10.1016\/j.cyto.2017.07.014_b0210","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4049\/jimmunol.151.3.1224","article-title":"IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression","volume":"151","author":"Ding","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2017.07.014_b0215","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/cyto.2000.0794","article-title":"Characterization of cytokine growth factor receptor, costimulatory and adhesion molecule expression patterns of bone marrow blasts in relapsed childhood B cell precursor all","volume":"13","author":"Kebelmann-Betzing","year":"2001","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2017.07.014_b0220","doi-asserted-by":"crossref","DOI":"10.3109\/10428194.2012.726721","article-title":"Role of interleukin-10 in the regulation of tumorigenicity of a T cell lymphoma","volume":"54","author":"Hassuneh","year":"2013","journal-title":"Leuk. Lymphoma."},{"key":"10.1016\/j.cyto.2017.07.014_b0225","first-page":"1","article-title":"IL10 receptor is a novel therapeutic target in DLBCLs","author":"B\u00e9guelin","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.cyto.2017.07.014_b0230","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1002\/1529-0131(200008)43:8<1790::AID-ANR15>3.0.CO;2-2","article-title":"Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic Lupus erythematosus","volume":"43","author":"Llorente","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2017.07.014_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2016.00050","article-title":"Enrichment of Inflammatory IL-17 and TNF-\u03b1 Secreting CD4+T Cells within Colorectal Tumors despite the Presence of Elevated CD39+T Regulatory Cells and Increased Expression of the Immune Checkpoint Molecule, PD-1","volume":"6","author":"Dunne","year":"2016","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cyto.2017.07.014_b0240","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1074\/jbc.M308809200","article-title":"Functional Cooperation between Interleukin-17 and Tumor Necrosis Factor-?? Is Mediated by CCAAT\/Enhancer-binding Protein Family Members","volume":"279","author":"Ruddy","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2017.07.014_b0245","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/intimm\/dxp021","article-title":"Th17 cells: From precursors to players in inflammation and infection","volume":"21","author":"Awasthi","year":"2009","journal-title":"Int. Immunol."},{"key":"10.1016\/j.cyto.2017.07.014_b0250","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12967-015-0590-1","article-title":"IL-17\/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia","volume":"13","author":"Musuraca","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cyto.2017.07.014_b0255","doi-asserted-by":"crossref","first-page":"16606","DOI":"10.1073\/pnas.1210129109","article-title":"S. a. Apostolidis, M.S. Lo, V.C. Kyttaris, G.C. Tsokos, cAMP response element modulator controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus","volume":"109","author":"Hedrich","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cyto.2017.07.014_b0260","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/cas.12459","article-title":"Th17 cells and interleukin-17 increase with poor prognosis in patients with acute myeloid leukemia","volume":"105","author":"Han","year":"2014","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cyto.2017.07.014_b0265","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/734068","article-title":"Transcriptional and posttranscriptional regulations of the HLA-G gene","volume":"2014","author":"Castelli","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.cyto.2017.07.014_b0270","first-page":"1","article-title":"Hypoxia inducible factor-1 mediates the expression of the immune checkpoint HLA-G in glioma cells through hypoxia response element located in exon 2","author":"Yaghi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cyto.2017.07.014_b0275","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bcmd.2015.06.004","article-title":"IL-10 gene polymorphism and influence of chemotherapy on cytokine plasma levels in childhood acute lymphoblastic leukemia patients: IL-10 polymorphism and plasma levels in leukemia patients","volume":"55","author":"Hiroki","year":"2015","journal-title":"Blood Cells. Mol. Dis."},{"key":"10.1016\/j.cyto.2017.07.014_b0280","doi-asserted-by":"crossref","first-page":"8357","DOI":"10.1073\/pnas.0803341105","article-title":"Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6\u2013STAT3 signaling pathway","volume":"105","author":"Liang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cyto.2017.07.014_b0285","first-page":"878","article-title":"The pro- and anti-inflammatory properties of the cytokine interleukin-6","volume":"2011","author":"Scheller","year":"1813","journal-title":"Biochim. Biophys. Acta - Mol. Cell Res."},{"key":"10.1016\/j.cyto.2017.07.014_b0290","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0065-2776(07)96002-2","article-title":"Regulation of interferon-gamma during innate and adaptive immune responses","volume":"96","author":"Schoenborn","year":"2007","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.cyto.2017.07.014_b0295","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00262-006-0159-1","article-title":"Effects of interferon gamma on native human acute myelogenous leukaemia cells","volume":"56","author":"Ersvaer","year":"2007","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cyto.2017.07.014_b0300","doi-asserted-by":"crossref","first-page":"17779","DOI":"10.1074\/jbc.M100815200","article-title":"Interferon-\u03b3 Sensitizes Human Myeloid Leukemia Cells to Death Receptor-mediated Apoptosis by a Pleiotropic Mechanism","volume":"276","author":"Varela","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2017.07.014_b0305","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1038\/leu.2009.139","article-title":"IL-6, but not IFN-gamma, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing","volume":"23","author":"Regis","year":"2009","journal-title":"Leukemia."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617302144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617302144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:51:57Z","timestamp":1760907117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466617302144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":61,"alternative-id":["S1043466617302144"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2017.07.014","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokines and soluble HLA-G levels in bone marrow stroma and their association with the survival rate of patients exhibiting childhood T-cell acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2017.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}